Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Asthma Therapies Based on Child’s Genetics Benefit Care

Researchers believe that different versions of the gene responsible for making the beta-2 receptor can influence how well asthma treatments work.

Chronic Pulmonary Disorders

Gefapixant Significantly Reduced Cough Frequency in Chronic Cough Patients

Gefapixant (MK-7264) is an investigational, orally administered, selective P2X3 receptor antagonist for the potential treatment of refractory or unexplained chronic cough.

Chronic Pulmonary Disorders

Give Them Comfort: Controlling COPD Symptoms at the End of Life (Part I)

Patients' last days of COPD can be characterized by depression, anxiety, pain, and dyspnea. Clinicians must be alert to patient discomfort and offer appropriate palliative care and reassurance.

Asthma

Childhood Asthma and Future Respiratory Morbidity

Childhood asthma is linked with an increased risk of respiratory disease-related hospital admissions and death, a new study in Respiratory Medicine shows.

COPD

What Does COVID-19 Mean for COPD Patients?

New research suggests that chronic obstructive pulmonary disease (COPD) is linked with more severe outcomes from COVID-19 infection.

Cystic fibrosis

How Does Age Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

Age may impact outcomes in lung transplant recipients with cystic fibrosis, a new study shows.

Pulmonary Fibrosis

Guidance for Using High-Resolution CT for Interstitial Lung Disease

The Pulmonary Fibrosis Fdn has issued a position statement that serves as a guide for conducting high-resolution computed tomography of the thorax for interstitial lung disease.

Allergies

Xolair One Step Closer to Self-administration Approval

The FDA accepted a sBLA for a new self-administration option for Xolair (omalizumab) across all approved US indications, according to Genetech.

Other Chronic Diseases

FDA Approves Viltepso for Rare Duchenne Muscular Dystrophy Mutation

The FDA granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy in patients with a specific gene mutation.